Inactive Instrument
IRLAB Therapeutics AB Stock Nasdaq Stockholm
Stocks
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - SEK | - |
|
| 08/07 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| 01/07 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
| Market Cap | 196M 20.55M 17.86M 16.63M 15.27M 28.83M 1.96B 29.28M 76.92M 977M 77.18M 75.48M 3.27B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 196M 20.55M 17.86M 16.63M 15.27M 28.83M 1.96B 29.28M 76.92M 977M 77.18M 75.48M 3.27B | EV / Sales 2026 * |
1.92x | EV / Sales 2027 * | 1.38x |
| Free-Float |
81.63% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: IRLAB Therapeutics AB
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 01/08/2024 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 01/01/2013 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 01/01/2016 |
| Chairman | 73 | 07/05/2020 | |
| Chairman | 68 | 20/02/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.53% | -3.95% | +50.70% | +152.78% | 1,024B | |
| +0.21% | -2.68% | +53.20% | +50.87% | 618B | |
| -2.51% | -3.25% | +28.54% | +67.99% | 443B | |
| +0.06% | -0.42% | +37.53% | +31.06% | 349B | |
| -0.69% | -0.30% | +13.76% | +13.84% | 264B | |
| -7.37% | -4.40% | -0.74% | -43.66% | 209B | |
| -0.64% | +2.43% | +29.74% | +67.16% | 208B | |
| -0.82% | +0.70% | +15.05% | +72.05% | 162B | |
| +0.40% | +1.92% | +6.47% | -29.25% | 143B | |
| Average | -1.32% | -1.40% | +26.03% | +42.54% | 379.88B | |
| Weighted average by Cap. | -1.00% | -2.15% | +36.14% | +71.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 102M 10.69M 9.3M 8.65M 7.94M 15M 1.02B 15.24M 40.03M 508M 40.16M 39.28M 1.7B | 142M 14.87M 12.92M 12.03M 11.04M 20.86M 1.42B 21.18M 55.65M 707M 55.84M 54.61M 2.37B |
| Net income | -32.6M -3.42M -2.97M -2.77M -2.54M -4.8M -326M -4.87M -12.79M -162M -12.84M -12.55M -545M | 33.3M 3.49M 3.04M 2.83M 2.59M 4.9M 333M 4.97M 13.07M 166M 13.11M 12.82M 556M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Calendar
Select your edition
All financial news and data tailored to specific country editions
